FIELD: medicine.
SUBSTANCE: method involves a preclinical electroneuromyography (ENMG) of the neuromuscular apparatus of injured and intact lower extremities to measure a muscle response amplitude - an M-response. The findings are recorded. Starting from the second postoperative day, in the course of the drug-induced neuroprotective treatment and therapeutic exercises, the following therapy is additionally performed for 10-15 days. If the injured M-response amplitude is below 4.0 mV, while the respective intact value is more than 4.0 mV, the anti-inflammatory physical treatment covering the injured extremity is performed. If the injured M-response amplitude is more than 4.0 mV, while the respective intact value is below 4.0 mV, the stimulating passive physical treatment covering the intact extremity is performed. If the M-response amplitude of the injured and intact extremities is below 4.0 mV, the anti-inflammatory physical treatment covering the injured extremity and the stimulating passive physical treatment covering the intact extremity are performed. Three and six months following the surgical management, the repeated ENMG of the neuromuscular apparatus of the lower extremities to measure the M-response amplitude. If observing the preserving M-response amplitude below 4.0 mV on at least one lower extremity three months following the surgical management, the repeated complex of the drug-induced neuroprotective treatment and the stimulating passive physical treatment covering the neuromuscular apparatus of the hip with the M-response amplitude below 4.0 mV are performed. If observing the preserving M-response amplitude below 4.0 mV on at least one lower extremity six months following the surgical management, the repeated complex of the drug-induced neuroprotective treatment and the stimulating passive physical functional treatment covering the neuromuscular apparatus of the hip with the M-response amplitude below 4.0 mV are performed by walking electrical stimulation of the hip and shin.
EFFECT: method reduces the length of treatment and increases its effectiveness with decreasing a percentage of neurological complications by performing the individual complex exposure on the neuromuscular apparatus of the lower extremities taking into account the ENMG findings of the neuromuscular apparatus of the lower extremities.
2 cl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTION OF POSTOPERATIVE COMPLICATIONS IN PATIENTS SUFFERING DEGENERATE-DYSTROPHIC JOINT DISEASE OF LOWER EXTREMITIES | 2010 |
|
RU2432112C1 |
METHOD FOR CHOOSING TACTICS OF HIP JOINT DYSPLASIA SURGERY IN CHILDREN | 2015 |
|
RU2616126C1 |
METHOD OF TREATING SCIATIC NEUROPATHY FOLLOWING HIP REPLACEMENT OR ACETABULAR FACTURE | 2012 |
|
RU2504412C1 |
METHOD FOR CHOOSING SURGICAL APPROACH TO DYSPLASTIC COXARTHROSIS IN HIP REPLACEMENT | 2012 |
|
RU2498770C1 |
METHOD OF MINIMALLY INVASIVE EXTERNALLY LATERAL APPROACH TO HIP JOINT IN PRIMARY TOTAL HIP REPLACEMENT | 2010 |
|
RU2481799C2 |
DIAGNOSTIC TECHNIQUE OF LEVEL OF DAMAGE OF ISCHIAL NERVE | 2019 |
|
RU2712807C1 |
METHOD OF REHABILITATION AFTER TOTAL KNEE ENDOPROSTHESIS REPLACEMENTIN PATIENTS WITH SARCOPENIA | 2018 |
|
RU2684178C1 |
METHOD FOR ANESTHESIA AT ENDOPROSTHETICS OF HIP JOINT IN SENILE PATIENTS | 2005 |
|
RU2278695C1 |
METHOD OF SURGICAL MINI-ACCESS IN HIP REPLACEMENT | 2018 |
|
RU2676655C1 |
METHOD OF ENDOPROSTHESIS FOR HIP JOINT IN CASE OF MALIGNANT TUMOR | 1991 |
|
RU2012269C1 |
Authors
Dates
2014-09-20—Published
2013-06-25—Filed